Home » Topics » Biomarkers, BioWorld Science

Biomarkers, BioWorld Science
RSS

TGase-2 correlated with reduced survival in lung cancer

Nov. 16, 2011

Chemokine as proinflammatory signal after traumatic brain injury

Nov. 16, 2011

Gen-Probe files notice relating to FDA review of Progensa PCA3 assay

Nov. 9, 2011

GLCCI1 gene variants linked to response to inhaled glucocorticoid asthma therapy

Nov. 9, 2011

CancerTYPE ID test can improve outcome of patients with cancer

Nov. 7, 2011

FDA approves highly specific HPV assay

Nov. 3, 2011

Potential new target for MS therapy discovered at U.S. univeristy

Nov. 3, 2011

Scientists in Sweden identify new biomarker for disease activity in MS

Nov. 2, 2011

St. Jude Medical diagnostic technology cleared for use in U.S.

Oct. 31, 2011

First-in-human data on PET tracer BAY-86-9596

Oct. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...